IRIS
BAROCELLI, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.232
AS - Asia 13.859
EU - Europa 11.144
SA - Sud America 1.873
AF - Africa 779
Continente sconosciuto - Info sul continente non disponibili 35
OC - Oceania 13
Totale 48.935
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.741
SG - Singapore 4.866
CN - Cina 4.169
VN - Vietnam 2.217
FI - Finlandia 1.997
SE - Svezia 1.754
IE - Irlanda 1.650
BR - Brasile 1.481
IT - Italia 1.376
DE - Germania 1.253
UA - Ucraina 978
HK - Hong Kong 944
FR - Francia 497
ZA - Sudafrica 491
TR - Turchia 480
GB - Regno Unito 415
NL - Olanda 396
CA - Canada 305
IN - India 279
RU - Federazione Russa 197
AR - Argentina 151
BD - Bangladesh 149
BE - Belgio 129
CI - Costa d'Avorio 119
MX - Messico 104
AT - Austria 96
JP - Giappone 92
IQ - Iraq 89
ES - Italia 88
ID - Indonesia 75
PH - Filippine 74
PL - Polonia 64
CZ - Repubblica Ceca 62
PK - Pakistan 62
KR - Corea 61
RO - Romania 60
EC - Ecuador 58
TH - Thailandia 50
CO - Colombia 41
VE - Venezuela 37
PY - Paraguay 34
MA - Marocco 33
EU - Europa 32
TW - Taiwan 30
LT - Lituania 29
CM - Camerun 26
UZ - Uzbekistan 25
CL - Cile 24
EG - Egitto 22
AZ - Azerbaigian 21
KE - Kenya 21
MY - Malesia 21
SA - Arabia Saudita 21
JO - Giordania 20
PA - Panama 19
PE - Perù 16
TN - Tunisia 16
AE - Emirati Arabi Uniti 14
UY - Uruguay 14
ET - Etiopia 13
BO - Bolivia 12
NP - Nepal 12
AL - Albania 11
AU - Australia 11
BG - Bulgaria 11
HU - Ungheria 11
IR - Iran 11
CR - Costa Rica 10
JM - Giamaica 10
KZ - Kazakistan 10
OM - Oman 10
CH - Svizzera 9
DO - Repubblica Dominicana 9
DZ - Algeria 9
IL - Israele 9
HN - Honduras 7
HR - Croazia 7
LB - Libano 7
SI - Slovenia 7
SN - Senegal 7
BY - Bielorussia 6
GE - Georgia 6
SC - Seychelles 6
TT - Trinidad e Tobago 6
BB - Barbados 5
DK - Danimarca 5
EE - Estonia 5
NI - Nicaragua 5
PT - Portogallo 5
QA - Qatar 5
RS - Serbia 5
SY - Repubblica araba siriana 5
BH - Bahrain 4
GA - Gabon 4
KG - Kirghizistan 4
LU - Lussemburgo 4
MD - Moldavia 4
PS - Palestinian Territory 4
SV - El Salvador 4
AO - Angola 3
Totale 48.883
Salva come PNG Salva come JPEG
Città #
Dallas 5.839
Singapore 2.594
Ashburn 1.772
Chandler 1.661
Dublin 1.649
San Jose 1.222
Jacksonville 1.112
Santa Clara 1.026
Beijing 990
Ann Arbor 894
Hong Kong 883
Dearborn 768
Ho Chi Minh City 680
Boardman 534
Parma 470
Hanoi 468
Johannesburg 468
Nanjing 428
Izmir 398
New York 356
Los Angeles 313
Princeton 310
Shanghai 308
Munich 294
Lauterbourg 288
Wilmington 213
San Mateo 210
Hefei 189
Toronto 180
Helsinki 178
Bremen 151
São Paulo 144
Hebei 133
Kunming 133
Nanchang 132
Buffalo 131
Shenyang 126
Brussels 125
Jinan 121
Abidjan 119
Moscow 108
Des Moines 99
Haiphong 97
Guangzhou 94
Frankfurt am Main 92
Columbus 88
Grafing 84
Vienna 83
Woodbridge 83
Tianjin 80
Council Bluffs 79
Da Nang 79
Tokyo 78
Turku 74
Chicago 70
Seattle 70
Changsha 64
Jiaxing 63
London 61
Rio de Janeiro 57
Fremont 53
Brooklyn 52
Montreal 51
Houston 48
Warsaw 48
Bologna 46
Milan 46
Hangzhou 42
The Dalles 41
Norwalk 40
Chennai 39
Jakarta 38
Orem 38
Zhengzhou 38
Amsterdam 36
Atlanta 36
Phoenix 35
Auburn Hills 33
Ottawa 33
Belo Horizonte 32
Denver 32
Biên Hòa 31
Nuremberg 31
Poplar 31
Pune 31
Stockholm 31
Brno 30
Hải Dương 29
Manchester 29
Marseille 29
Baghdad 28
Boston 28
Mexico City 28
Redondo Beach 28
Bangalore 27
Can Tho 27
Modena 27
West Jordan 27
Curitiba 26
Seoul 26
Totale 31.014
Salva come PNG Salva come JPEG
Nome #
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5 amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6 carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10Hpyrimido[1,2-a [1,8]naphthyridine-6-carboxamide derivative 1.683
1,5-Benzodiazepines Part XIII. Substututed 4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-amines and 4H-imidazo-[1,2-a][ 1,5]benzodiazepin-5-amines as analgesic, anti-inflammatory and/or antipyretic agents with low acute toxicity 1.672
1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists 1.629
1,5-Benzodiazepin tricyclic derivatives as analgersic, anti-inflammatory and /or antipyretic agents with very low acute gastrolesivity and toxicity 1.613
1,8-Naphthyridines V. Novel N-substituted 5-amino-N,N-diethyl-9-isopropyl [1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamides, as potent anti-inflammatory and/or analgesic agents completely devoid of acute gastrolesivity 250
Targeting the Eph/ephrin system as anti-inflammatory strategy in IBD 250
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 244
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach 240
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 239
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line 232
2-Aminobenzimidazoles as new potent H3-antagonists 223
Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model 221
3D-printed chitosan-based scaffolds: An in vitro study of human skin cell growth and an in-vivo wound healing evaluation in experimental diabetes in rats 213
Antiplatelet and antithrombotic activities of essential oil from wild Ocotea quixos (Lam.) Kosterm. (Lauraceae) calices from Amazonian Ecuador 210
Bifidobacterium bifidum PRL2010 alleviates intestinal ischemia/reperfusioni injury 207
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 204
Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model 204
Development of an orally bioavailable small molecule targeting Eph-ephrin system: in vitro and in vivo anticancer activity. 202
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 201
Antinociceptive and gastroprotective effects of inhaled and orally administered Lavandula hybrida Reverchon “Grosso” essential oil 200
Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor. 200
Increased Mucosal Thrombin is Associated with Crohn's Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation 199
Amino acid derivatives as palmitoylethanolamide prodrugs: Synthesis, in vitro metabolism and in vivo plasma profile in rats 198
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations. 197
Analgesic properties of benzisothiazole/ benzimidazole derivatives with acidic groups 196
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 196
Aminobenzimidazoles as new potent H3-antagonists 195
Comparison of the effects of structurally different H2-antagonists on acid and pepsin activity stimulated by dimaprit in conscious cats 193
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 193
Protective Effects of a Protease Inhibitor (Gabexate Mesilate) on Intestinal Ischemia/Reperfusion Injury in Rats 192
Discovery and development of Eph-ephrin antagonists endowed with antiangiogenic properties 191
Polyphenol rich botanicals used as food supplements interfere with EphA2-ephrinA1 system. 190
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 190
1,8-Naphthyridines VII. New substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides and their isosteric analogues, exhibiting notable anti-inflammatory and/or analgesic activities, but no acute gastrolesivity. 190
Azionifarmacologiche di composti alchilaminoalchilfenilbenzisotiazolici sul trattogastrointestinale 189
1,8-Naphthyridines VIII. Novel 5-aminoimidazo[1,2-a] [1,8]naphthyridine-6-carboxamide and 5-amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamide derivatives showing potent analgesic or anti-inflammatory activity, respectively, and completely devoid of acute gastrolesivity. 189
2,4-Substituted benzopyrano[4,3-d]pyrimidines and benzopyrano[4,3-d]pyrimidin-5-ones: synthesis and antiplatelet activity 188
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 187
[Experimental tracheal transplantation. Literature review and proposal of an original surgical technique]. 183
2-Amino-1,2-benzisothiazolin-3-one derivatives as powerful antiplatelet agents 183
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism. 182
Design and structure-activity relationship of amino acid derivatives of lithocholic acid as novel EphA2 antagonists 182
Impact of S1P mimetics on mesenteric ischemia/reperfusion injury 182
Caratterizzazione farmacologica in vitro di nuovi agonisti muscarinici analoghi dell'Oxotremorina 179
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation 177
NEW EPH ANTAGONISTS DISCRIMINATING BETWEEN EPH-AS AND EPH-BS CLASSES 176
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 176
Structure–Activity Relationships and Mechanism of Action of Eph–ephrin Antagonists: Interaction of Cholanic Acid with the EphA2 Receptor 176
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 175
Gastrointestinal symptoms and local oxidative stress in a model of Parkinson's Disease in rats 175
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 174
Daily assumption of fermented milk containing Bifidobacterium breve 246 B® promotes prophylactic effects against intestinal inflammation in mice 174
4-(1,2-benzisothiazol-3-)alkanoic and phenylalkanoic acids: synthesis and anti-inflammatory, analgesic and antipyretic activities 173
Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation 171
4-(3-Oxo-1,2-benzisothiazolin-2-yl)alkanoic, phenyl and phenoxyalkanoic acids: synthesis and anti-inflammatory, analgesic, and antipyretic properties 171
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 169
Adaptive changes in rat ileum motility induced by mild mesenteric ischemia/reperfusion injury: role of endogenous mediators and reperfusion time 168
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 168
Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma 168
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 167
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 166
The anti-H1-histaminic and antimuscarinic effect of 2- and 4-[benzyl-(2-dimethylaminoethyl)amino]pyrimidine compounds]. 166
270 Discovery, development and optimization of low molecular weight EPH–ephrin protein–protein inhibitors 166
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 166
Novel Analgesic Agents Obtained by Molecular Hybridization of Orthosteric and Allosteric Ligands 165
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 163
A New Potent and Selective Histamine H3-Receptor Antagonist, 4(5)-{2-[4(5)-cyclohexylimidazol-2-ylthio]ethyl}imidazole 163
Analgesici-antipiretici benzopirano pirimidinici non acidici attivi per via orale privi di gastrolesività 163
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 163
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 162
A preliminary study of engineered nanoparticles effects on barrier function of airway epithelial monolayers 162
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 162
Development of 3-oxo-cholenic derivatives as Eph antagonists able to block in vitro angiogenesis 162
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 162
Perturbation of The EphA2-EphrinA1 System in Human Prostate Cancer Cells by Colonic (Poly)phenol Catabolites 161
Discovery and development of small molecules targeting Eph-ephrin system in glioblastoma: an academic history 161
UniPR1331: small Eph/ephrin antagonist beneficial in intestinal inflammation by interfering with type-B signaling 161
Human colonoid-derived monolayers and Caco-2: comparative analysis of inflammatory responses 160
Biochemical platform for the identification of adverse effects triggered by free hemoglobin in guinea pigs 160
Dual role of endogenous serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-induced colitis 160
2-Amino-1,2-benzisothiazolin-3-one Derivatives: Synthesis and Assessment of their Antiplatelet/Spasmolytic Effects 160
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 160
5-HT1A receptors as target to protect the intestine in an experimental model of colitis 159
Analgesic activity of new hybrid muscarinic agonists in mice 159
Inflammatory proteases released in a mouse model of intestinal ischemia 158
Antinociceptive affects of inhalated and orally administered Lavandula hybrida Reverchon "Grosso" essential oil 157
Anomalous responses to histamine stimulation of guinea-pig oesophageal muscularis mucosae. 157
Effect of μ Opioid Receptor Activation On Intestinal Ischemia/Reperfusion Injury in Mice 157
Botanicals used as food supplements interfering with EphA2-ephrinA1 system: a screening study 157
Hake fish bone as a calcium source for efficient bone mineralization 157
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 157
Eph/ephrin targeting with a small molecule improves glucose tolerance in healthy and insulin-resistant mice 156
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 156
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 155
Antiulcer long-term treatment in chronic ulcer rat 153
Discovery of small-molecule targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases 152
5-Alkoxy-2-hydrazino and 5-methoxy-2-amino-5H[1]benzopyrano[4,3-d]pyrimidines: synthesis and pharmacological activity 152
Anomalous responses to histamine stimulation of guinea-pig oesophageal muscularis mucosae 152
Intestinal Hypoxia and reperfusion: role for Eph-ephrin system 152
Nuovi potenti agonisti muscarinici oxotremorina-M simili a struttura acetilenica: studio funzionale in vitro 151
Totale 23.830
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.882
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021510 0 0 0 0 0 0 0 0 0 96 336 78
2021/20221.869 64 57 53 239 117 126 199 213 71 125 116 489
2022/20236.474 760 675 390 473 646 725 111 361 1.997 57 199 80
2023/20242.213 128 194 59 88 168 565 211 119 85 111 160 325
2024/20257.401 229 397 514 411 723 870 281 353 817 690 628 1.488
2025/202620.341 1.559 2.604 5.657 1.642 2.238 965 1.729 564 2.276 1.107 0 0
Totale 49.267